<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Nephrology Headlines</title>
		<link>http://www.medscape.com/nephrology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Nephrology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Nephrology Headlines</title>
			<link>http://www.medscape.com/nephrology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2008, Medscape</copyright>
		<pubDate>Thu, 24 Jul 2008 18:05:08 EDT</pubDate>
		<managingEditor>nephrologyeditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Reversal of Proteinuric Renal Disease and the Emerging Role of Endothelin</title>
			<link>http://www.medscape.com/viewprogram/15682?src=rss</link>
			<description>Endothelin has a prominent role in the pathogenesis of proteinuric renal disease. The current article examines how endothelin promotes renal disease as well as medications that can antagonize endothelin.  &lt;br /&gt; &lt;i&gt;Nature Clinical Practice Nephrology&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Thu, 24 Jul 2008 12:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Everolimus Potential Alternative for Metastatic Renal Cell Carcinoma</title>
			<link>http://www.medscape.com/viewarticle/577979?src=rss</link>
			<description>The mammalian target of rapamycin might prolong progression-free survival in patients who have already tried other targeted therapies.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 24 Jul 2008 08:49:20 EDT</pubDate>
		</item>
		<item>
			<title>ASCO 2008: Genitourinary Cancer</title>
			<link>http://www.medscape.com/viewprogram/15716?src=rss</link>
			<description>Important new data about drug treatment of renal and prostate cancers, as reported at ASCO 2008, are highlighted by experts.  &lt;br /&gt; &lt;i&gt;Medscape Hematology-Oncology&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Wed, 23 Jul 2008 12:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Advances in the Treatment of Renal Cell Carcinoma</title>
			<link>http://www.medscape.com/viewarticle/577723?src=rss</link>
			<description>Several important advances in targeted and other therapies for renal cell carcinoma are reviewed in this report from ASCO 2008. 
  &lt;br /&gt; &lt;i&gt;Medscape Hematology-Oncology&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Wed, 23 Jul 2008 15:09:14 EDT</pubDate>
		</item>
		<item>
			<title>New Guidelines About Diagnosis and Treatment of Children and Infants With Stroke</title>
			<link>http://www.medscape.com/viewarticle/577821?src=rss</link>
			<description>Mark Alberts, MD, discusses new guidelines concerning the diagnosis and treatment of children and infants who have a stroke in his videoblog. 
  &lt;br /&gt; &lt;i&gt;Medscape Neurology &amp; Neurosurgery&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Wed, 23 Jul 2008 15:44:02 EDT</pubDate>
		</item>
		<item>
			<title>Race Not a Determinant of Outcome at One Year After PCI</title>
			<link>http://www.medscape.com/viewarticle/577936?src=rss</link>
			<description>African-American patients and Caucasian patients have similar 1-year outcome after percutaneous coronary intervention (PCI), but chronic kidney disease (CKD) has a significant adverse effect on mortality, investigators report.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Thu, 24 Jul 2008 09:51:01 EDT</pubDate>
		</item>
		<item>
			<title>Reduced Creatinine Clearance and Microalbuminuria Both Predict Stroke</title>
			<link>http://www.medscape.com/viewarticle/577962?src=rss</link>
			<description>Impairment of the glomerular filtration rate (GFR) and the glomerular filtration barrier are independently associated with stroke, according to an analysis of data from the 1999-2004 National Health and Nutrition Examination Surveys (NHANES).  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Neurology &amp; Neurosurgery</category>
					<pubDate>Thu, 24 Jul 2008 09:52:58 EDT</pubDate>
		</item>
		<item>
			<title>Physicians for Sale: How Medical Professional Organizations Exploit Their Members</title>
			<link>http://www.medscape.com/viewarticle/577178?src=rss</link>
			<description>To improve the state of US healthcare, physicians need to rethink what their profession is and identify what they need to do to regain their professional integrity. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Mon, 21 Jul 2008 08:50:07 EDT</pubDate>
		</item>
		<item>
			<title>Gadolinium-Based Contrast Raises Nephrogenic Systemic Fibrosis Risk</title>
			<link>http://www.medscape.com/viewarticle/577838?src=rss</link>
			<description>Gadolinium-based contrast material used in magnetic resonance imaging (MRI) increases the risk for nephrogenic systemic fibrosis (NSF), according to a report in the June issue of the American Journal of Kidney Diseases.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Tue, 22 Jul 2008 11:21:11 EDT</pubDate>
		</item>
		<item>
			<title>Building Physician Connectivity for e-Prescribing</title>
			<link>http://www.medscape.com/viewarticle/577274?src=rss</link>
			<description>Kevin Hutchinson, President and Chief Executive Officer of Prematics, Inc., in Vienna, Virginia, tells us how to move e-prescribing forward. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Fri, 18 Jul 2008 08:53:10 EDT</pubDate>
		</item>
		<item>
			<title>Kidney Disease Linked to Lower Medication Use Post-MI</title>
			<link>http://www.medscape.com/viewarticle/577714?src=rss</link>
			<description>Kidney disease is linked to lower medication use after myocardial infarction, but this is unlikely to explain the worse long-term outcomes, a new study suggests.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Fri, 18 Jul 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Survival Impact of Vitamin D Therapy in Hemodialysis Patients</title>
			<link>http://www.medscape.com/viewarticle/576843?src=rss</link>
			<description>Lavinia Aura Negrea, MD, Assistant Professor of Medicine at Case Western University, reviews recent survival data and the role of vitamin D supplementation in patients with chronic kidney disease. 
  &lt;br /&gt; &lt;i&gt;Medscape Nephrology&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Thu, 17 Jul 2008 10:48:24 EDT</pubDate>
		</item>
		<item>
			<title>News From Clinical Trials in Multifactorial Hypertension</title>
			<link>http://www.medscape.com/viewarticle/576348?src=rss</link>
			<description>ASH 2008: Substudy and other data from the ON-TARGET, TRANSCEND, AASK, ACCORD, EXCEED, and ACCOMPLISH trials. 
  &lt;br /&gt; &lt;i&gt;Medscape Cardiology&lt;/i&gt;</description>
			<category>Cardiology</category>
					<pubDate>Thu, 17 Jul 2008 17:13:31 EDT</pubDate>
		</item>
		<item>
			<title>Astellas Wins Japan Approval for Once-Daily Formulation of Tacrolimus</title>
			<link>http://www.medscape.com/viewarticle/577708?src=rss</link>
			<description>Astellas Pharma Inc said on Thursday it had won approval to sell a new version of its key transplant drug in Japan, the second major region where it has gained approval although it is facing delays in the United States.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Business of Medicine</category>
					<pubDate>Thu, 17 Jul 2008 18:20:14 EDT</pubDate>
		</item>
		<item>
			<title>Renal Transplant Ups Risk of Complications of Chronic Kidney Disease in Children</title>
			<link>http://www.medscape.com/viewarticle/577695?src=rss</link>
			<description>Anemia and hypertension occur more often in children and adolescents with chronic kidney disease (CKD) who have undergone a kidney transplant than in those with CKD in native kidneys, results of a study published in the June issue of the American Journal of Kidney Diseases indicate.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Thu, 17 Jul 2008 18:39:10 EDT</pubDate>
		</item>
		<item>
			<title>Reverse Transcriptase Inhibitors Promising Against Renal Clear-Cell Carcinoma</title>
			<link>http://www.medscape.com/viewarticle/577654?src=rss</link>
			<description>The non-nucleoside reverse transcriptase (RT) inhibitors efavirenz and nevirapine induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma (RCC), according to Italian researchers.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 17 Jul 2008 11:26:19 EDT</pubDate>
		</item>
		<item>
			<title>Talactoferrin Promising Against Metastatic Kidney Cancer</title>
			<link>http://www.medscape.com/viewarticle/577638?src=rss</link>
			<description>Talactoferrin, a recombinant form of human lactoferrin, shows activity against metastatic renal cell carcinoma (RCC) in previously treated patients, according to a report in the July 1st issue of Cancer.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Thu, 17 Jul 2008 11:27:27 EDT</pubDate>
		</item>
		<item>
			<title>Rituximab Plus IVIG Useful for Desensitization During Renal Transplantation</title>
			<link>http://www.medscape.com/viewarticle/577650?src=rss</link>
			<description>In kidney transplant candidates highly sensitized to HLA, treatment with rituximab plus intravenous immune globulin (IVIG) may cut anti-HLA antibody levels and improve transplantation rates, the results of an open-label, phase 1-2 study suggest.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Transplantation</category>
					<pubDate>Thu, 17 Jul 2008 11:29:49 EDT</pubDate>
		</item>
		<item>
			<title>Oxalate in Renal Stone Disease: The Terminal Metabolite That Just Won&apos;t Go Away</title>
			<link>http://www.medscape.com/viewarticle/576926?src=rss</link>
			<description>Learn more about the function of oxalate and its potential roles in nephrolithiasis and nephrocalcinosis in this review of animal studies. 
  &lt;br /&gt; &lt;i&gt;Nature Clinical Practice Nephrology&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Wed, 23 Jul 2008 15:38:59 EDT</pubDate>
		</item>
		<item>
			<title>Sensitivity of International Classification of Diseases Codes for Hyponatremia Among Commercially Insured Outpatients in the United States</title>
			<link>http://www.medscape.com/viewarticle/576538?src=rss</link>
			<description>Should International Classification of Diseases Codes be used to identify outpatient hyponatremia incidence? Uncover what these study authors found in a commercially insured population. 
  &lt;br /&gt; &lt;i&gt;BMC Nephrology&lt;/i&gt;</description>
			<category>Nephrology</category>
					<pubDate>Mon, 21 Jul 2008 15:08:21 EDT</pubDate>
		</item>

</channel>
</rss>